eFFECTOR Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
27 Nov 23 | SellUS$369,457 | SR One Capital Management, LP | Company | 24,366.52 | US$15.16 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 47,162 | 1% |
Public Companies | 75,152 | 1.6% |
Institutions | 241,905 | 5.14% |
General Public | 4,340,190 | 92.3% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 82%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
113,054 | US$22.6 | 0% | 100.0% | |||
75,152 | US$15.0 | 0% | no data | |||
61,758 | US$12.3 | -82.5% | no data | |||
52,343 | US$10.5 | 0% | no data | |||
34,987 | US$7.0 | 0% | no data | |||
14,602 | US$2.9 | 0% | no data | |||
7,136 | US$1.4 | 0% | no data | |||
3,117 | US$0.6 | 0% | no data | |||
1,200 | US$0.2 | 0% | no data | |||
361 | US$0.07 | 0% | no data | |||
361 | US$0.07 | 0% | no data | |||
100 | US$0.02 | 0% | no data | |||
48 | US$0.01 | 0% | no data |